MC1R, the cAMP pathway, and the response to solar UV: Extending the horizon beyond pigmentation

Pigment Cell and Melanoma Research

Volumn 27, Issue 5, 2014, Pages 699-720

  García Borrón, Jose C ^a,b   Abdel Malek, Zalfa ^c   Jiménez Cervantes, Celia ^a,b  

^a UNIVERSITY OF MURCIA   (Spain)

^b IMIB Arrixaca Instituto Murciano de Investigación Biomédica   (Spain)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

CAMP; MC1R variants; Melanocortin 1 receptor; Melanocytes; Melanoma; Ultraviolet radiation

Indexed keywords

CYCLIC AMP; LIGAND; MELANOCORTIN 1 RECEPTOR;

ADVERSE EFFECTS; ALLELE; ANIMAL; CYTOLOGY; DNA DAMAGE; GENE EXPRESSION PROFILING; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; HUMAN; MELANOCYTE; MELANOMA; METABOLISM; MOUSE; MUTATION; NEOPLASMS, RADIATION-INDUCED; PHENOTYPE; PHYSIOLOGY; PIGMENTATION; PROTEIN PROCESSING; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; SKIN PIGMENTATION; ULTRAVIOLET RADIATION;

ALLELES; ANIMALS; CYCLIC AMP; DNA DAMAGE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LIGANDS; MELANOCYTES; MELANOMA; MICE; MUTATION; NEOPLASMS, RADIATION-INDUCED; PHENOTYPE; PIGMENTATION; POLYMORPHISM, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECEPTOR, MELANOCORTIN, TYPE 1; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; SKIN PIGMENTATION; ULTRAVIOLET RAYS;

EID: 84907976862     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12257     Document Type: Review

References (255)

1. Abdel-Malek, Z., Swope, V.B., Suzuki, I., Akcali, C., Harriger, M.D., Boyce, S.T., Urabe, K., and Hearing, V.J. (1995). Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc. Natl. Acad. Sci. U. S. A. 92, 1789-1793.
2. Abdel-Malek, Z.A., Kadekaro, A.L., Kavanagh, R.J. et al. (2006). Melanoma prevention strategy based on using tetrapeptide alpha-MSH analogs that protect human melanocytes from UV-induced DNA damage and cytotoxicity. FASEB J. 20, 1561-1563.
3. Abdel-Malek, Z.A., Ruwe, A., Kavanagh-Starner, R., Kadekaro, A.L., Swope, V., Haskell-Luevano, C., Koikov, L., and Knittel, J.J. (2009). alpha-MSH tripeptide analogs activate the melanocortin 1 receptor and reduce UV-induced DNA damage in human melanocytes. Pigment Cell Melanoma Res. 22, 635-644.
4. Aberdam, E., Bertolotto, C., Sviderskaya, E.V., de Thilot, V., Hemesath, T.J., Fisher, D.E., Bennett, D.C., Ortonne, J.P., and Ballotti, R. (1998). Involvement of microphthalmia in the inhibition of melanocyte lineage differentiation and of melanogenesis by agouti signal protein. J. Biol. Chem. 273, 19560-19565.
5. Abrisqueta, M., Herraiz, C., Perez Oliva, A.B., Sanchez-Laorden, B.L., Olivares, C., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2013). Differential and competitive regulation of human melanocortin 1 receptor signaling by beta-arrestin isoforms. J. Cell Sci. 126, 3724-3737.
6. Ainger, S.A., Wong, S.S., Roberts, D.W., Leonard, J.H., and Sturm, R.A. (2011). Effect of MC1R variant allele status on MSH-ligand induction of dopachrome tautomerase in melanocytes co-cultured with keratinocytes. Exp. Dermatol. 20, 681-684.
7. Aoki, H., and Moro, O. (2002). Involvement of microphthalmia-associated transcription factor (MITF) in expression of human melanocortin-1 receptor (MC1R). Life Sci. 71, 2171-2179.
8. Audet, M., and Bouvier, M. (2012). Restructuring G-protein- coupled receptor activation. Cell 151, 14-23.
9. Baig, A.H., Swords, F.M., Szaszak, M., King, P.J., Hunyady, L., and Clark, A.J. (2002). Agonist activated adrenocorticotropin receptor internalizes via a clathrin-mediated G protein receptor kinase dependent mechanism. Endocr. Res. 28, 281-289.
10. Bause, E. (1983). Structural requirements of N-glycosylation of proteins. Studies with proline peptides as conformational probes. Biochem. J. 209, 331-336.
11. Beaumont, K.A., Newton, R.A., Smit, D.J., Leonard, J.H., Stow, J.L., and Sturm, R.A. (2005). Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum. Mol. Genet. 14, 2145-2154.
12. Beaumont, K.A., Shekar, S.N., Newton, R.A., James, M.R., Stow, J.L., Duffy, D.L., and Sturm, R.A. (2007). Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. Hum. Mol. Genet. 16, 2249-2260.
13. Beaumont, K.A., Wong, S.S., Ainger, S.A. et al. (2011). Melanocortin MC(1) receptor in human genetics and model systems. Eur. J. Pharmacol. 660, 103-110.
14. Beaumont, K.A., Smit, D.J., Liu, Y.Y., Chai, E., Patel, M.P., Millhauser, G.L., Smith, J.J., Alewood, P.F., and Sturm, R.A. (2012). Melanocortin-1 receptor-mediated signalling pathways activated by NDP-MSH and HBD3 ligands. Pigment Cell Melanoma Res. 25, 370-374.
15. Bellei, B., Maresca, V., Flori, E., Pitisci, A., Larue, L., and Picardo, M. (2010). p38 regulates pigmentation via proteasomal degradation of tyrosinase. J. Biol. Chem. 285, 7288-7299.
16. Bellei, B., Pitisci, A., Izzo, E., and Picardo, M. (2012). Inhibition of melanogenesis by the pyridinyl imidazole class of compounds: possible involvement of the Wnt/beta-catenin signaling pathway. PLoS ONE 7, e33021.
17. Benned-Jensen, T., Mokrosinski, J., and Rosenkilde, M.M. (2011). The E92K melanocortin 1 receptor mutant induces cAMP production and arrestin recruitment but not ERK activity indicating biased constitutive signaling. PLoS ONE 6, e24644.
18. Bertolotto, C., Abbe, P., Hemesath, T.J., Bille, K., Fisher, D.E., Ortonne, J.P., and Ballotti, R. (1998). Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J. Cell Biol. 142, 827-835.
19. Bicknell, A.B. (2008). The tissue-specific processing of pro-opiomelanocortin. J. Neuroendocrinol. 20, 692-699.
20. Biebermann, H., Krude, H., Elsner, A., Chubanov, V., Gudermann, T., and Gruters, A. (2003). Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes 52, 2984-2988.
21. Bohm, M., Moellmann, G., Cheng, E., Alvarez-Franco, M., Wagner, S., Sassone-Corsi, P., and Halaban, R. (1995). Identification of p90RSK as the probable CREB-Ser133 kinase in human melanocytes. Cell Growth Differ. 6, 291-302.
22. Bohm, M., Wolff, I., Scholzen, T.E., Robinson, S.J., Healy, E., Luger, T.A., Schwarz, T., and Schwarz, A. (2005). alpha-Melanocyte-stimulating hormone protects from ultraviolet radiation-induced apoptosis and DNA damage. J. Biol. Chem. 280, 5795-5802.
23. Bohm, M., Luger, T.A., Tobin, D.J., and Garcia-Borron, J.C. (2006). Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology. J. Invest Dermatol. 126, 1966-1975.
24. Bolognia, J., Murray, M., and Pawelek, J. (1989). UVB-induced melanogenesis may be mediated through the MSH-receptor system. J. Invest Dermatol. 92, 651-656.
25. Bonilla, C., Boxill, L.A., Donald, S.A. et al. (2005). The 8818G allele of the agouti signaling protein (ASIP) gene is ancestral and is associated with darker skin color in African Americans. Hum. Genet. 116, 402-406.
26. Box, N.F., Wyeth, J.R., O'Gorman, L.E., Martin, N.G., and Sturm, R.A. (1997). Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum. Mol. Genet. 6, 1891-1897.
27. Box, N.F., Duffy, D.L., Chen, W., Stark, M., Martin, N.G., Sturm, R.A., and Hayward, N.K. (2001). MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am. J. Hum. Genet. 69, 765-773.
28. Breit, A., Wolff, K., Kalwa, H., Jarry, H., Buch, T., and Gudermann, T. (2006). The natural inverse agonist agouti-related protein induces arrestin-mediated endocytosis of melanocortin-3 and -4 receptors. J. Biol. Chem. 281, 37447-37456.
29. Brenner, M., and Hearing, V.J. (2008). The protective role of melanin against UV damage in human skin. Photochem. Photobiol. 84, 539-549.
30. Busca, R., and Ballotti, R. (2000). Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res. 13, 60-69.
31. Busca, R., Abbe, P., Mantoux, F., Aberdam, E., Peyssonnaux, C., Eychene, A., Ortonne, J.P., and Ballotti, R. (2000). Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J. 19, 2900-2910.
32. Candille, S.I., Kaelin, C.B., Cattanach, B.M. et al. (2007). A -defensin mutation causes black coat color in domestic dogs. Science 318, 1418-1423.
33. Cao, J., Wan, L., Hacker, E. et al. (2013). MC1R is a potent regulator of PTEN after UV exposure in melanocytes. Mol. Cell 51, 409-422.
34. Carreira, S., Goodall, J., Aksan, I., La Rocca, S.A., Galibert, M.D., Denat, L., Larue, L., and Goding, C.R. (2005). Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression. Nature 433, 764-769.
35. Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K.S., Testori, A., Larue, L., and Goding, C.R. (2006). Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 20, 3426-3439.
36. Chai, B.X., Neubig, R.R., Millhauser, G.L. et al. (2003). Inverse agonist activity of agouti and agouti-related protein. Peptides 24, 603-609.
37. Chakraborty, A.K., Orlow, S.J., Bolognia, J.L., and Pawelek, J.M. (1991). Structural/functional relationships between internal and external MSH receptors: modulation of expression in Cloudman melanoma cells by UVB radiation. J. Cell. Physiol. 147, 1-6.
38. Chakraborty, A.K., Funasaka, Y., Slominski, A., Ermak, G., Hwang, J., Pawelek, J.M., and Ichihashi, M. (1996). Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim. Biophys. Acta 1313, 130-138.
39. Chhajlani, V., and Wikberg, J.E. (1996). Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA (FEBS 11553). FEBS Lett. 390, 238.
40. Chluba-de, T.J., Bagutti, C., Cotti, R., and Eberle, A.N. (1996). Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene. J. Cell Sci. 109(Pt 8), 2023-2030.
41. Cho, D.H., Bae, C.D., and Juhnn, Y.S. (2000). Multi-facet expressions of adenylate cyclase isoforms in B16-F10 melanoma cells differentiated by forskolin treatment. Exp. Mol. Med. 32, 235-242.
42. Conti, M., and Beavo, J. (2007). Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu. Rev. Biochem. 76, 481-511.
43. Cooper, D.M. (2003). Regulation and organization of adenylyl cyclases and cAMP. Biochem. J. 375, 517-529.
44. Corre, S., Primot, A., Sviderskaya, E., Bennett, D.C., Vaulont, S., Goding, C.R., and Galibert, M.D. (2004). UV-induced expression of key component of the tanning process, the POMC and MC1R genes, is dependent on the p-38-activated upstream stimulating factor-1 (USF-1). J. Biol. Chem. 279, 51226-51233.
45. Corre, S., Mekideche, K., Adamski, H., Mosser, J., Watier, E., and Galibert, M.D. (2006). In vivo and ex vivo UV-induced analysis of pigmentation gene expressions. J. Invest Dermatol. 126, 916-918.
46. Corre, S., Primot, A., Baron, Y., Le, S.J., Goding, C., and Galibert, M.D. (2009). Target gene specificity of USF-1 is directed via p38-mediated phosphorylation-dependent acetylation. J. Biol. Chem. 284, 18851-18862.
47. Cui, R., Widlund, H.R., Feige, E. et al. (2007). Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 128, 853-864.
48. Dalziel, M., Nunes, N.M., and Furger, A. (2007). Two G-rich regulatory elements located adjacent to and 440 nucleotides downstream of the core poly(A) site of the intronless melanocortin receptor 1 gene are critical for efficient 3′ end processing. Mol. Cell. Biol. 27, 1568-1580.
49. Dalziel, M., Kolesnichenko, M., das Neves, R.P., Iborra, F., Goding, C., and Furger, A. (2011). Alpha-MSH regulates intergenic splicing of MC1R and TUBB3 in human melanocytes. Nucleic Acids Res. 39, 2378-2392.
50. Davies, J.R., Randerson-Moor, J., Kukalizch, K. et al. (2012). Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study. Pigment Cell Melanoma Res. 25, 384-394.
51. DeFea, K.A. (2011). Beta-arrestins as regulators of signal termination and transduction: how do they determine what to scaffold? Cell. Signal. 23, 621-629.
52. Delaney, A., Keighren, M., Fleetwood-Walker, S.M., and Jackson, I.J. (2010). Involvement of the melanocortin-1 receptor in acute pain and pain of inflammatory but not neuropathic origin. PLoS ONE 5, e12498.
53. Demenais, F., Mohamdi, H., Chaudru, V. et al. (2010). Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study. J. Natl Cancer Inst. 102, 1568-1583.
54. Dessinioti, C., Antoniou, C., Katsambas, A., and Stratigos, A.J. (2011). Melanocortin 1 receptor variants: functional role and pigmentary associations. Photochem. Photobiol. 87, 978-987.
55. DeWire, S.M., Ahn, S., Lefkowitz, R.J., and Shenoy, S.K. (2007). Beta-arrestins and cell signaling. Annu. Rev. Physiol. 69, 483-510.
56. D'Orazio, J., and Fisher, D.E. (2011). Central role for cAMP signaling in pigmentation and UV resistance. Cell Cycle 10, 8-9.
57. D'Orazio, J.A., Nobuhisa, T., Cui, R. et al. (2006). Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning. Nature 443, 340-344.
58. Doyle, J.R., Fortin, J.P., Beinborn, M., and Kopin, A.S. (2012). Selected melanocortin 1 receptor single-nucleotide polymorphisms differentially alter multiple signaling pathways. J. Pharmacol. Exp. Ther. 342, 318-326.
59. Duffy, D.L., Box, N.F., Chen, W., Palmer, J.S., Montgomery, G.W., James, M.R., Hayward, N.K., Martin, N.G., and Sturm, R.A. (2004). Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum. Mol. Genet. 13, 447-461.
60. Elfakir, A., Ezzedine, K., Latreille, J. et al. (2010). Functional MC1R-gene variants are associated with increased risk for severe photoaging of facial skin. J. Invest Dermatol. 130, 1107-1115.
61. Fabrikant, J., Touloei, K., and Brown, S.M. (2013). A review and update on melanocyte stimulating hormone therapy: afamelanotide. J. Drugs Dermatol. 12, 775-779.
62. Fargnoli, M.C., Gandini, S., Peris, K., Maisonneuve, P., and Raimondi, S. (2010). MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis. Eur. J. Cancer 46, 1413-1420.
63. Fogarty, G.B., Muddle, R., Sprung, C.N., Chen, W., Duffy, D., Sturm, R.A., and McKay, M.J. (2010). Unexpectedly severe acute radiotherapy side effects are associated with single nucleotide polymorphisms of the melanocortin-1 receptor. Int. J. Radiat. Oncol. Biol. Phys. 77, 1486-1492.
64. Frandberg, P.A., Doufexis, M., Kapas, S., and Chhajlani, V. (1998). Human pigmentation phenotype: a point mutation generates nonfunctional MSH receptor. Biochem. Biophys. Res. Commun. 245, 490-492.
65. Frandberg, P.A., Doufexis, M., Kapas, S., and Chhajlani, V. (2001). Cysteine residues are involved in structure and function of melanocortin 1 receptor: substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist. Biochem. Biophys. Res. Commun. 281, 851-857.
66. Fuller, B.B., and Meyskens, F.L. Jr (1981). Endocrine responsiveness in human melanocytes and melanoma cells in culture. J. Natl Cancer Inst. 66, 799-802.
67. Funasaka, Y., Chakraborty, A.K., Hayashi, Y., Komoto, M., Ohashi, A., Nagahama, M., Inoue, Y., Pawelek, J., and Ichihashi, M. (1998). Modulation of melanocyte-stimulating hormone receptor expression on normal human melanocytes: evidence for a regulatory role of ultraviolet B, interleukin-1alpha, interleukin-1beta, endothelin-1 and tumour necrosis factor-alpha. Br. J. Dermatol. 139, 216-224.
68. Galibert, M.D., and Corre, S. (2010). In vivo and in vitro tools to identify and study transcriptional regulation of USF-1 target genes. Methods Mol. Biol. 647, 339-355.
69. Galibert, M.D., Carreira, S., and Goding, C.R. (2001). The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced Tyrosinase expression. EMBO J. 20, 5022-5031.
70. Gao, X., Simon, K.C., Han, J., Schwarzschild, M.A., and Ascherio, A. (2009). Genetic determinants of hair color and Parkinson's disease risk. Ann. Neurol. 65, 76-82.
71. Garcia-Borron, J.C., Sanchez-Laorden, B.L., and Jimenez-Cervantes, C. (2005). Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res. 18, 393-410.
72. Gerstenblith, M.R., Goldstein, A.M., Fargnoli, M.C., Peris, K., and Landi, M.T. (2007). Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum. Mutat. 28, 495-505.
73. Geschwind, I.I. (1966). Change in hair color in mice induced by injection of alpha-MSH. Endocrinology 79, 1165-1167.
74. Graham, A., Wakamatsu, K., Hunt, G., Ito, S., and Thody, A.J. (1997). Agouti protein inhibits the production of eumelanin and phaeomelanin in the presence and absence of alpha-melanocyte stimulating hormone. Pigment Cell Res. 10, 298-303.
75. Guan, X., Niu, J., Liu, Z., Wang, L.E., Amos, C.I., Lee, J.E., Gershenwald, J.E., Grimm, E.A., and Wei, Q. (2013). Variants in melanocortin 1 receptor gene contribute to risk of melanoma-a direct sequencing analysis in a Texas population. Pigment Cell Melanoma Res. 26, 422-425.
76. Gudbjartsson, D.F., Sulem, P., Stacey, S.N. et al. (2008). ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat. Genet. 40, 886-891.
77. Gurevich, E.V., and Gurevich, V.V. (2006). Arrestins: ubiquitous regulators of cellular signaling pathways. Genome Biol. 7, 236.
78. Gurevich, E.V., Tesmer, J.J., Mushegian, A., and Gurevich, V.V. (2012). G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol. Ther. 133, 40-69.
79. Hacker, E., Boyce, Z., Kimlin, M.G., Wockner, L., Pollak, T., Vaartjes, S.A., Hayward, N.K., and Whiteman, D.C. (2013). The effect of MC1R variants and sunscreen on the response of human melanocytes in vivo to ultraviolet radiation and implications for melanoma. Pigment Cell Melanoma Res. 26, 835-844.
80. Halaban, R., Tyrrell, L., Longley, J., Yarden, Y., and Rubin, J. (1993). Pigmentation and proliferation of human melanocytes and the effects of melanocyte-stimulating hormone and ultraviolet B light. Ann. N. Y. Acad. Sci. 680, 290-301.
81. Harding, R.M., Healy, E., Ray, A.J. et al. (2000). Evidence for variable selective pressures at MC1R. Am. J. Hum. Genet. 66, 1351-1361.
82. Healy, E., Flannagan, N., Ray, A., Todd, C., Jackson, I.J., Matthews, J.N., Birch-Machin, M.A., and Rees, J.L. (2000). Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair. Lancet 355, 1072-1073.
83. Healy, E., Jordan, S.A., Budd, P.S., Suffolk, R., Rees, J.L., and Jackson, I.J. (2001). Functional variation of MC1R alleles from red-haired individuals. Hum. Mol. Genet. 10, 2397-2402.
84. Hemesath, T.J., Price, E.R., Takemoto, C., Badalian, T., and Fisher, D.E. (1998). MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature 391, 298-301.
85. Herraiz, C., Jimenez-Cervantes, C., Zanna, P., and Garcia-Borron, J.C. (2009). Melanocortin 1 receptor mutations impact differentially on signalling to the cAMP and the ERK mitogen-activated protein kinase pathways. FEBS Lett. 583, 3269-3274.
86. Herraiz, C., Journe, F., Abdel-Malek, Z., Ghanem, G., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2011a). Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. Mol. Endocrinol. 25, 138-156.
87. Herraiz, C., Sanchez-Laorden, B.L., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2011b). N-glycosylation of the human melanocortin 1 receptor: occupancy of glycosylation sequons and functional role. Pigment Cell Melanoma Res. 24, 479-489.
88. Herraiz, C., Journe, F., Ghanem, G., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2012). Functional status and relationships of melanocortin 1 receptor signaling to the cAMP and extracellular signal-regulated protein kinases 1 and 2 pathways in human melanoma cells. Int. J. Biochem. Cell Biol. 44, 2244-2252.
89. Hida, T., Wakamatsu, K., Sviderskaya, E.V. et al. (2009). Agouti protein, mahogunin, and attractin in pheomelanogenesis and melanoblast-like alteration of melanocytes: a cAMP-independent pathway. Pigment Cell Melanoma Res. 22, 623-634.
90. Hodis, E., Watson, I.R., Kryukov, G.V. et al. (2012). A landscape of driver mutations in melanoma. Cell 150, 251-263.
91. Holst, B., and Schwartz, T.W. (2003). Molecular mechanism of agonism and inverse agonism in the melanocortin receptors: Zn(2+) as a structural and functional probe. Ann. N. Y. Acad. Sci. 994, 1-11.
92. Houslay, M.D. (2010). Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown. Trends Biochem. Sci. 35, 91-100.
93. Hunt, G., and Thody, A.J. (1995). Agouti protein can act independently of melanocyte-stimulating hormone to inhibit melanogenesis. J. Endocrinol. 147, R1-R4.
94. Hunt, G., Donatien, P.D., Lunec, J., Todd, C., Kyne, S., and Thody, A.J. (1994). Cultured human melanocytes respond to MSH peptides and ACTH. Pigment Cell Res. 7, 217-221.
95. Hunt, G., Kyne, S., Ito, S., Wakamatsu, K., Todd, C., and Thody, A. (1995). Eumelanin and phaeomelanin contents of human epidermis and cultured melanocytes. Pigment Cell Res. 8, 202-208.
96. Ibarrola-Villava, M., Peña-Chilet, M., Llorca-Cardeñosa, M.J., Oltra, S., Cadenas, C.M., Bravo, J., and Ribas, G. (2014). Modeling MC1R rare variants: a structural evaluation of variants detected in a Mediterranean case-control study. J. Invest Dermatol. 134, 1146-1149.
97. Ichii-Jones, F., Lear, J.T., Heagerty, A.H. et al. (1998). Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J. Invest Dermatol. 111, 218-221.
98. Im, S., Moro, O., Peng, F., Medrano, E.E., Cornelius, J., Babcock, G., Nordlund, J.J., and Abdel-Malek, Z.A. (1998). Activation of the cyclic AMP pathway by alpha-melanotropin mediates the response of human melanocytes to ultraviolet B radiation. Cancer Res. 58, 47-54.
99. d'Ischia, M., Wakamatsu, K., Napolitano, A. et al. (2013). Melanins and melanogenesis: methods, standards, protocols. Pigment Cell Melanoma Res. 26, 616-633.
100. Ito, S., and Wakamatsu, K. (2003). Quantitative analysis of eumelanin and pheomelanin in humans, mice, and other animals: a comparative review. Pigment Cell Res. 16, 523-531.
101. Ito, S., and Wakamatsu, K. (2011). Human hair melanins: what we have learned and have not learned from mouse coat color pigmentation. Pigment Cell Melanoma Res. 24, 63-74.
102. Jablonski, N.G., and Chaplin, G. (2010). Colloquium paper: human skin pigmentation as an adaptation to UV radiation. Proc. Natl. Acad. Sci. U. S. A. 107(Suppl 2), 8962-8968.
103. Jimenez-Cervantes, C., Martinez-Esparza, M., Perez, C., Daum, N., Solano, F., and Garcia-Borron, J.C. (2001a). Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor. J. Cell Sci. 114, 2335-2344.
104. Jimenez-Cervantes, C., Olivares, C., Gonzalez, P., Morandini, R., Ghanem, G., and Garcia-Borron, J.C. (2001b). The Pro162 variant is a loss-of-function mutation of the human melanocortin 1 receptor gene. J. Invest Dermatol. 117, 156-158.
105. Kadekaro, A.L., Kavanagh, R., Kanto, H. et al. (2005). alpha-Melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res. 65, 4292-4299.
106. Kadekaro, A.L., Leachman, S., Kavanagh, R.J. et al. (2010). Melanocortin 1 receptor genotype: an important determinant of the damage response of melanocytes to ultraviolet radiation. FASEB J. 24, 3850-3860.
107. Kadekaro, A.L., Chen, J., Yang, J., Chen, S., Jameson, J., Swope, V.B., Cheng, T., Kadakia, M., and Abdel-Malek, Z. (2012). Alpha-melanocyte-stimulating hormone suppresses oxidative stress through a p53-mediated signaling pathway in human melanocytes. Mol. Cancer Res. 10, 778-786.
108. Kane, E.V., Painter, D., Roman, E., Allan, J., Law, G., and Lightfoot, T. (2010). Melanocortin 1 receptor (MC1R), pigmentary characteristics and sun exposure: findings from a case-control study of diffuse large B-cell and follicular lymphoma. Cancer Epidemiol. 34, 136-141.
109. Kanetsky, P.A., Swoyer, J., Panossian, S., Holmes, R., Guerry, D., and Rebbeck, T.R. (2002). A polymorphism in the agouti signaling protein gene is associated with human pigmentation. Am. J. Hum. Genet. 70, 770-775.
110. Kanetsky, P.A., Rebbeck, T.R., Hummer, A.J. et al. (2006). Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res. 66, 9330-9337.
111. Katritch, V., Cherezov, V., and Stevens, R.C. (2013). Structure-function of the G protein-coupled receptor superfamily. Annu. Rev. Pharmacol. Toxicol. 53, 531-556.
112. Kennedy, C., Ter, H.J., Berkhout, M., Gruis, N., Bastiaens, M., Bergman, W., Willemze, R., and Bavinck, J.N. (2001). Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J. Invest Dermatol. 117, 294-300.
113. Khaled, M., Levy, C., and Fisher, D.E. (2010). Control of melanocyte differentiation by a MITF-PDE4D3 homeostatic circuit. Genes Dev. 24, 2276-2281.
114. Khlgatian, M.K., Hadshiew, I.M., Asawanonda, P., Yaar, M., Eller, M.S., Fujita, M., Norris, D.A., and Gilchrest, B.A. (2002). Tyrosinase gene expression is regulated by p53. J. Invest Dermatol. 118, 126-132.
115. Kilianova, Z., Basora, N., Kilian, P., Payet, M.D., and Gallo-Payet, N. (2006). Human melanocortin receptor 2 expression and functionality: effects of protein kinase A and protein kinase C on desensitization and internalization. Endocrinology 147, 2325-2337.
116. Kinsler, V.A., Abu-Amero, S., Budd, P. et al. (2012). Germline melanocortin-1-receptor genotype is associated with severity of cutaneous phenotype in congenital melanocytic nevi: a role for MC1R in human fetal development. J. Invest Dermatol. 132, 2026-2032.
117. Kokot, A., Metze, D., Mouchet, N., Galibert, M.D., Schiller, M., Luger, T.A., and Bohm, M. (2009). Alpha-melanocyte-stimulating hormone counteracts the suppressive effect of UVB on Nrf2 and Nrf-dependent gene expression in human skin. Endocrinology 150, 3197-3206.
118. Krauthammer, M., Kong, Y., Ha, B.H. et al. (2012). Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat. Genet. 44, 1006-1014.
119. Krude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G., and Gruters, A. (1998). Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19, 155-157.
120. Lalueza-Fox, C., Rompler, H., Caramelli, D. et al. (2007). A melanocortin 1 receptor allele suggests varying pigmentation among Neanderthals. Science 318, 1453-1455.
121. Landi, M.T., Kanetsky, P.A., Tsang, S. et al. (2005). MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J. Natl Cancer Inst. 97, 998-1007.
122. Landi, M.T., Bauer, J., Pfeiffer, R.M. et al. (2006). MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313, 521-522.
123. Le Pape, E., Wakamatsu, K., Ito, S., Wolber, R., and Hearing, V.J. (2008). Regulation of eumelanin/pheomelanin synthesis and visible pigmentation in melanocytes by ligands of the melanocortin 1 receptor. Pigment Cell Melanoma Res. 21, 477-486.
124. Le Pape, E., Passeron, T., Giubellino, A., Valencia, J.C., Wolber, R., and Hearing, V.J. (2009). Microarray analysis sheds light on the dedifferentiating role of agouti signal protein in murine melanocytes via the Mc1r. Proc. Natl. Acad. Sci. U. S. A. 106, 1802-1807.
125. Lerner, A.B., and McGuire, J.S. (1961). Effect of alpha- and betamelanocyte stimulating hormones on the skin colour of man. Nature 189, 176-179.
126. Lerner, A.B., and McGuire, J.S. (1964). Melanocyte-stimulating hormone and adrenocorticotrophic hormone. their relation to pigmentation. N. Engl. J. Med. 270, 539-546.
127. Levine, N., Sheftel, S.N., Eytan, T., Dorrr, R.T., Hadley, M.E., Weinrach, J.C., Ertl, G.A., Toth, K., McGee, D.L., and Hruby, V.J. (1991). Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. JAMA 266, 2730-2736.
128. Levy, C., Khaled, M., and Fisher, D.E. (2006). MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol. Med. 12, 406-414.
129. Lin, J.Y., and Fisher, D.E. (2007). Melanocyte biology and skin pigmentation. Nature 445, 843-850.
130. Lu, D., Willard, D., Patel, I.R. et al. (1994). Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371, 799-802.
131. Lu, D., Vage, D.I., and Cone, R.D. (1998). A ligand-mimetic model for constitutive activation of the melanocortin-1 receptor. Mol. Endocrinol. 12, 592-604.
132. Luttrell, L.M., and Gesty-Palmer, D. (2010). Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol. Rev. 62, 305-330.
133. Maccioni, L., Rachakonda, P.S., Scherer, D., Bermejo, J.L., Planelles, D., Requena, C., Hemminki, K., Nagore, E., and Kumar, R. (2013). Variants at chromosome 20 (ASIP locus) and melanoma risk. Int. J. Cancer 132, 42-54.
134. Mandrika, I., Petrovska, R., and Wikberg, J. (2005). Melanocortin receptors form constitutive homo- and heterodimers. Biochem. Biophys. Res. Commun. 326, 349-354.
135. Maresca, V., Flori, E., Bellei, B., Aspite, N., Kovacs, D., and Picardo, M. (2010). MC1R stimulation by alpha-MSH induces catalase and promotes its re-distribution to the cell periphery and dendrites. Pigment Cell Melanoma Res. 23, 263-275.
136. Markovic, D. (2013). Alternative mRNA splicing of G protein-coupled receptors. Methods Enzymol. 520, 323-335.
137. Markovic, D., and Challiss, R.A. (2009). Alternative splicing of G protein-coupled receptors: physiology and pathophysiology. Cell. Mol. Life Sci. 66, 3337-3352.
138. Marquette, A., Andre, J., Bagot, M., Bensussan, A., and Dumaz, N. (2011). ERK and PDE4 cooperate to induce RAF isoform switching in melanoma. Nat. Struct. Mol. Biol. 18, 584-591.
139. Martinez-Cadenas, C., Lopez, S., Ribas, G. et al. (2013). Simultaneous purifying selection on the ancestral MC1R allele and positive selection on the melanoma-risk allele V60L in south Europeans. Mol. Biol. Evol. 30, 2654-2665.
140. Martinez-Esparza, M., Jimenez-Cervantes, C., Beermann, F., Aparicio, P., Lozano, J.A., and Garcia-Borron, J.C. (1997). Transforming growth factor-beta1 inhibits basal melanogenesis in B16/F10 mouse melanoma cells by increasing the rate of degradation of tyrosinase and tyrosinase-related protein-1. J. Biol. Chem. 272, 3967-3972.
141. Martinez-Esparza, M., Jimenez-Cervantes, C., Solano, F., Lozano, J.A., and Garcia-Borron, J.C. (1998). Mechanisms of melanogenesis inhibition by tumor necrosis factor-alpha in B16/F10 mouse melanoma cells. Eur. J. Biochem. 255, 139-146.
142. Martinez-Esparza, M., Solano, F., and Garcia-Borron, J.C. (1999). Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes. Cell Mol. Biol. (Noisy. -le-grand). 45, 991-1000.
143. Mas, J.S., Gerritsen, I., Hahmann, C., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2003). Rate limiting factors in melanocortin 1 receptor signalling through the cAMP pathway. Pigment Cell Res. 16, 540-547.
144. Meyskens, F.L. Jr, Farmer, P., and Fruehauf, J.P. (2001). Redox regulation in human melanocytes and melanoma. Pigment Cell Res. 14, 148-154.
145. Meziani, R., Descamps, V., Gerard, B. et al. (2005). Association study of the g.8818A>G polymorphism of the human agouti gene with melanoma risk and pigmentary characteristics in a French population. J. Dermatol. Sci. 40, 133-136.
146. Miccadei, S., Pascucci, B., Picardo, M., Natali, P.G., and Civitareale, D. (2008). Identification of the minimal melanocyte-specific promoter in the melanocortin receptor 1 gene. J. Exp. Clin. Cancer Res. 27, 71.
147. Miller, M.W., Duhl, D.M., Vrieling, H., Cordes, S.P., Ollmann, M.M., Winkes, B.M., and Barsh, G.S. (1993). Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev. 7, 454-467.
148. Moore, C.A., Milano, S.K., and Benovic, J.L. (2007). Regulation of receptor trafficking by GRKs and arrestins. Annu. Rev. Physiol. 69, 451-482.
149. Moro, O., Ideta, R., and Ifuku, O. (1999). Characterization of the promoter region of the human melanocortin-1 receptor (MC1R) gene. Biochem. Biophys. Res. Commun. 262, 452-460.
150. Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., and Cone, R.D. (1992). The cloning of a family of genes that encode the melanocortin receptors. Science 257, 1248-1251.
151. Muffley, L.A., Zhu, K.Q., Engrav, L.H., Gibran, N.S., and Hocking, A.M. (2011). Spatial and temporal localization of the melanocortin 1 receptor and its ligand alpha-melanocyte-stimulating hormone during cutaneous wound repair. J. Histochem. Cytochem. 59, 278-288.
152. Murata, T., Shimizu, K., Watanabe, Y., Morita, H., Sekida, M., and Tagawa, T. (2010). Expression and role of phosphodiesterase 5 in human malignant melanoma cell line. Anticancer Res. 30, 355-358.
153. Myles, P.S., Buchanan, F.F., and Bain, C.R. (2012). The effect of hair colour on anaesthetic requirements and recovery time after surgery. Anaesth. Intensive Care 40, 683-689.
154. Nakayama, K., Soemantri, A., Jin, F. et al. (2006). Identification of novel functional variants of the melanocortin 1 receptor gene originated from Asians. Hum. Genet. 119, 322-330.
155. Narita, M., Murata, T., Shimizu, K., Nakagawa, T., Sugiyama, T., Inui, M., Hiramoto, K., and Tagawa, T. (2007). A role for cyclic nucleotide phosphodiesterase 4 in regulation of the growth of human malignant melanoma cells. Oncol. Rep. 17, 1133-1139.
156. Newton, R.A., Smit, S.E., Barnes, C.C., Pedley, J., Parsons, P.G., and Sturm, R.A. (2005). Activation of the cAMP pathway by variant human MC1R alleles expressed in HEK and in melanoma cells. Peptides 26, 1818-1824.
157. Newton, R.A., Roberts, D.W., Leonard, J.H., and Sturm, R.A. (2007). Human melanocytes expressing MC1R variant alleles show impaired activation of multiple signaling pathways. Peptides 28, 2387-2396.
158. Nix, M.A., Kaelin, C.B., Ta, T., Weis, A., Morton, G.J., Barsh, G.S., and Millhauser, G.L. (2013). Molecular and functional analysis of human beta-defensin 3 action at melanocortin receptors. Chem. Biol. 20, 784-795.
159. Nyan, D.C., Anbazhagan, R., Hughes-Darden, C.A., and Wachira, S.J. (2008). Endosomal colocalization of melanocortin-3 receptor and beta-arrestins in CAD cells with altered modification of AKT/PKB. Neuropeptides 42, 355-366.
160. Oertel, B., and Lotsch, J. (2008). Genetic mutations that prevent pain: implications for future pain medication. Pharmacogenomics 9, 179-194.
161. Oiso, N., Kishida, K., Fukai, K., Motokawa, T., Hosomi, N., Suzuki, T., Mitsuhashi, Y., Tsuboi, R., and Kawada, A. (2009). A Japanese piebald patient with auburn hair colour associated with a novel mutation p. P832L in the KIT gene and a homozygous variant p.I120T in the MC1R gene. Br. J. Dermatol. 161, 468-469.
162. Ollmann, M.M., Lamoreux, M.L., Wilson, B.D., and Barsh, G.S. (1998). Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo. Genes Dev. 12, 316-330.
163. Palmer, J.S., Duffy, D.L., Box, N.F., Aitken, J.F., O'Gorman, L.E., Green, A.C., Hayward, N.K., Martin, N.G., and Sturm, R.A. (2000). Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am. J. Hum. Genet. 66, 176-186.
164. Park, H.Y., Russakovsky, V., Ao, Y., Fernandez, E., and Gilchrest, B.A. (1996). Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C. Exp. Cell Res. 227, 70-79.
165. Patel, M.P., Cribb Fabersunne, C.S., Yang, Y.K., Kaelin, C.B., Barsh, G.S., and Millhauser, G.L. (2010). Loop-swapped chimeras of the agouti-related protein and the agouti signaling protein identify contacts required for melanocortin 1 receptor selectivity and antagonism. J. Mol. Biol. 404, 45-55.
166. Pawelek, J., Wong, G., Sansone, M., and Morowitz, J. (1973). Molecular biology of pigment cells. Molecular controls in mammalian pigmentation. Yale J. Biol. Med. 46, 430-443.
167. Perez Oliva, A.B., Fernendez, L.P., Detorre, C. et al. (2009). Identification and functional analysis of novel variants of the human melanocortin 1 receptor found in melanoma patients. Hum. Mutat.
168. Piechowski, C.L., Rediger, A., Lagemann, C. et al. (2013). Inhibition of melanocortin-4 receptor dimerization by substitutions in intracellular loop 2. J. Mol. Endocrinol. 51, 109-118.
169. Pollock, P.M., Harper, U.L., Hansen, K.S. et al. (2003). High frequency of BRAF mutations in nevi. Nat. Genet. 33, 19-20.
170. Price, E.R., Horstmann, M.A., Wells, A.G., Weilbaecher, K.N., Takemoto, C.M., Landis, M.W., and Fisher, D.E. (1998). alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J. Biol. Chem. 273, 33042-33047.
171. Pucci, M., Pasquariello, N., Battista, N. et al. (2012). Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor. J. Biol. Chem. 287, 15466-15478.
172. Qanbar, R., and Bouvier, M. (2003). Role of palmitoylation/depalmitoylation reactions in G-protein-coupled receptor function. Pharmacol. Ther. 97, 1-33.
173. Rana, B.K., Hewett-Emmett, D., Jin, L. et al. (1999). High polymorphism at the human melanocortin 1 receptor locus. Genetics 151, 1547-1557.
174. Rees, J.L. (2004). The genetics of sun sensitivity in humans. Am. J. Hum. Genet. 75, 739-751.
175. Ringholm, A., Klovins, J., Rudzish, R., Phillips, S., Rees, J.L., and Schioth, H.B. (2004). Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair. J. Invest Dermatol. 123, 917-923.
176. Robbins, L.S., Nadeau, J.H., Johnson, K.R., Kelly, M.A., Roselli-Rehfuss, L., Baack, E., Mountjoy, K.G., and Cone, R.D. (1993). Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72, 827-834.
177. Roberts, D.W., Newton, R.A., Beaumont, K.A., Helen, L.J., and Sturm, R.A. (2006). Quantitative analysis of MC1R gene expression in human skin cell cultures. Pigment Cell Res. 19, 76-89.
178. Roberts, D.W., Newton, R.A., and Sturm, R.A. (2007). MC1R expression in skin: is it confined to melanocytes? J. Invest Dermatol. 127, 2472-2473.
179. Roberts, D.W., Newton, R.A., Leonard, J.H., and Sturm, R.A. (2008). Melanocytes expressing MC1R polymorphisms associated with red hair color have altered MSH-ligand activated pigmentary responses in coculture with keratinocytes. J. Cell. Physiol. 215, 344-355.
180. Rodrigues, A.R., Almeida, H., and Gouveia, A.M. (2012). Melanocortin 5 receptor signaling and internalization: role of MAPK/ERK pathway and beta-arrestins 1/2. Mol. Cell. Endocrinol. 361, 69-79.
181. Rodrigues, A.R., Sousa, D., Almeida, H., and Gouveia, A.M. (2013). Structural determinants regulating cell surface targeting of melanocortin receptors. J. Mol. Endocrinol. 51, R23-R32.
182. Ronai, Z. (2013). The masters talk: the PGC-1alpha-MITF axis as a melanoma energizer. Pigment Cell Melanoma Res 26, 294-295.
183. Rouzaud, F., Annereau, J.P., Valencia, J.C., Costin, G.E., and Hearing, V.J. (2003). Regulation of melanocortin 1 receptor expression at the mRNA and protein levels by its natural agonist and antagonist. FASEB J. 17, 2154-2156.
184. Rouzaud, F., Costin, G.E., Yamaguchi, Y. et al. (2006). Regulation of constitutive and UVR-induced skin pigmentation by melanocortin 1 receptor isoforms. FASEB J. 20, 1927-1929.
185. Roy, S., Perron, B., and Gallo-Payet, N. (2010). Role of asparagine-linked glycosylation in cell surface expression and function of the human adrenocorticotropin receptor (melanocortin 2 receptor) in 293/FRT cells. Endocrinology 151, 660-670.
186. Roy, S., Pinard, S., Chouinard, L., and Gallo-Payet, N. (2011a). Adrenocorticotropin hormone (ACTH) effects on MAPK phosphorylation in human fasciculata cells and in embryonic kidney 293 cells expressing human melanocortin 2 receptor (MC2R) and MC2R accessory protein (MRAP)beta. Mol. Cell. Endocrinol. 336, 31-40.
187. Roy, S., Roy, S.J., Pinard, S., Taillefer, L.D., Rached, M., Parent, J.L., and Gallo-Payet, N. (2011b). Mechanisms of melanocortin-2 receptor (MC2R) internalization and recycling in human embryonic kidney (hek) cells: identification of Key Ser/Thr (S/T) amino acids. Mol. Endocrinol. 25, 1961-1977.
188. Saha, B., Singh, S.K., Sarkar, C., Bera, R., Ratha, J., Tobin, D.J., and Bhadra, R. (2006). Activation of the Mitf promoter by lipid-stimulated activation of p38-stress signalling to CREB. Pigment Cell Res. 19, 595-605.
189. Sakai, C., Ollmann, M., Kobayashi, T., Abdel-Malek, Z., Muller, J., Vieira, W.D., Imokawa, G., Barsh, G.S., and Hearing, V.J. (1997). Modulation of murine melanocyte function in vitro by agouti signal protein. EMBO J. 16, 3544-3552.
190. Salazar-Onfray, F., Lopez, M., Lundqvist, A. et al. (2002). Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker. Br. J. Cancer 87, 414-422.
191. Saleha, S.B., Ajaml, M., Jamil, M., Nasir, M., and Hameed, A. (2013). MC1R gene mutation and its association with oculocutaneous albinism type (OCA) phenotype in a consanguineous Pakistani family. J. Dermatol. Sci. 70, 68-70.
192. Samuels, M.E., Gallo-Payet, N., Pinard, S. et al. (2013). Bioinactive ACTH causing glucocorticoid deficiency. J. Clin. Endocrinol. Metab. 98, 736-742.
193. Sanchez, M.J., Olivares, S.C., Ghanem, G., Haycock, J., Lozano Teruel, J.A., Garcia-Borron, J.C., and Jimenez-Cervantes, C. (2002). Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function. Eur. J. Biochem. 269, 6133-6141.
194. Sanchez-Laorden, B.L., Sanchez-Mas, J., Martinez-Alonso, E., Martinez-Menarguez, J.A., Garcia-Borron, J.C., and Jimenez-Cervantes, C. (2006a). Dimerization of the human melanocortin 1 receptor: functional consequences and dominant-negative effects. J. Invest Dermatol. 126, 172-181.
195. Sanchez-Laorden, B.L., Sanchez-Mas, J., Turpin, M.C., Garcia-Borron, J.C., and Jimenez-Cervantes, C. (2006b). Variant amino acids in different domains of the human melanocortin 1 receptor impair cell surface expression. Cell Mol. Biol. (Noisy. -le-grand). 52, 39-46.
196. Sanchez-Laorden, B.L., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2007). Regulation of human melanocortin 1 receptor signaling and trafficking by Thr-308 and Ser-316 and its alteration in variant alleles associated with red hair and skin cancer. J. Biol. Chem. 282, 3241-3251.
197. Sanchez-Laorden, B.L., Herraiz, C., Valencia, J.C., Hearing, V.J., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2009). Aberrant trafficking of human melanocortin 1 receptor variants associated with red hair and skin cancer: Steady-state retention of mutant forms in the proximal golgi. J. Cell. Physiol. 220, 640-654.
198. Sanchez-Mas, J., Hahmann, C., Gerritsen, I., Garcia-Borron, J.C., and Jimenez-Cervantes, C. (2004). Agonist-independent, high constitutive activity of the human melanocortin 1 receptor. Pigment Cell Res. 17, 386-395.
199. Sanchez-Mas, J., Guillo, L.A., Zanna, P., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2005a). Role of G protein-coupled receptor kinases in the homologous desensitization of the human and mouse melanocortin 1 receptors. Mol. Endocrinol. 19, 1035-1048.
200. Sanchez-Mas, J., Sanchez-Laorden, B.L., Guillo, L.A., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2005b). The melanocortin-1 receptor carboxyl terminal pentapeptide is essential for MC1R function and expression on the cell surface. Peptides 26, 1848-1857.
201. Savage, S.A., Gerstenblith, M.R., Goldstein, A.M., Mirabello, L., Fargnoli, M.C., Peris, K., and Landi, M.T. (2008). Nucleotide diversity and population differentiation of the melanocortin 1 receptor gene, MC1R. BMC Genet. 9, 31.
202. Sawyer, T.K., Hruby, V.J., Wilkes, B.C., Draelos, M.T., Hadley, M.E., and Bergsneider, M. (1982). Comparative biological activities of highly potent active-site analogues of alpha-melanotropin. J. Med. Chem. 25, 1022-1027.
203. Scherer, D., and Kumar, R. (2010). Genetics of pigmentation in skin cancer-a review. Mutat. Res. 705, 141-153.
204. Schioth, H.B., Phillips, S.R., Rudzish, R., Birch-Machin, M.A., Wikberg, J.E., and Rees, J.L. (1999). Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem. Biophys. Res. Commun. 260, 488-491.
205. Scott, M.C., Suzuki, I., and Abdel-Malek, Z.A. (2002a). Regulation of the human melanocortin 1 receptor expression in epidermal melanocytes by paracrine and endocrine factors and by ultraviolet radiation. Pigment Cell Res. 15, 433-439.
206. Scott, M.C., Wakamatsu, K., Ito, S. et al. (2002b). Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation. J. Cell Sci. 115, 2349-2355.
207. Sebag, J.A., and Hinkle, P.M. (2009). Opposite effects of the melanocortin-2 (MC2) receptor accessory protein MRAP on MC2 and MC5 receptor dimerization and trafficking. J. Biol. Chem. 284, 22641-22648.
208. Shinyama, H., Masuzaki, H., Fang, H., and Flier, J.S. (2003). Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization. Endocrinology 144, 1301-1314.
209. Siegrist, W., Stutz, S., and Eberle, A.N. (1994). Homologous and heterologous regulation of alpha-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines. Cancer Res. 54, 2604-2610.
210. Siegrist, W., Drozdz, R., Cotti, R., Willard, D.H., Wilkison, W.O., and Eberle, A.N. (1997). Interactions of alpha-melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti. J. Recept. Signal. Transduct. Res. 17, 75-98.
211. Singh, S.K., Sarkar, C., Mallick, S., Saha, B., Bera, R., and Bhadra, R. (2005). Human placental lipid induces melanogenesis through p38 MAPK in B16F10 mouse melanoma. Pigment Cell Res. 18, 113-121.
212. Singh, S.K., Abbas, W.A., and Tobin, D.J. (2012). Bone morphogenetic proteins differentially regulate pigmentation in human skin cells. J. Cell Sci. 125, 4306-4319.
213. Slominski, A., Wortsman, J., Luger, T., Paus, R., and Solomon, S. (2000). Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev. 80, 979-1020.
214. Slominski, A., Tobin, D.J., Shibahara, S., and Wortsman, J. (2004). Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol. Rev. 84, 1155-1228.
215. Slominski, A., Plonka, P.M., Pisarchik, A., Smart, J.L., Tolle, V., Wortsman, J., and Low, M.J. (2005). Preservation of eumelanin hair pigmentation in proopiomelanocortin-deficient mice on a nonagouti (a/a) genetic background. Endocrinology 146, 1245-1253.
216. Slominski, A., Wortsman, J., Tuckey, R.C., and Paus, R. (2007). Differential expression of HPA axis homolog in the skin. Mol. Cell. Endocrinol. 265-266, 143-149.
217. Smalley, K., and Eisen, T. (2000). The involvement of p38 mitogen-activated protein kinase in the alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenic and anti-proliferative effects in B16 murine melanoma cells. FEBS Lett. 476, 198-202.
218. Smalley, K.S., and Eisen, T.G. (2002). Differentiation of human melanoma cells through p38 MAP kinase is associated with decreased retinoblastoma protein phosphorylation and cell cycle arrest. Melanoma Res. 12, 187-192.
219. Smith, R., Healy, E., Siddiqui, S. et al. (1998). Melanocortin 1 receptor variants in an Irish population. J. Invest Dermatol. 111, 119-122.
220. Smith, A.G., Box, N.F., Marks, L.H., Chen, W., Smit, D.J., Wyeth, J.R., Huttley, G.A., Easteal, S., and Sturm, R.A. (2001). The human melanocortin-1 receptor locus: analysis of transcription unit, locus polymorphism and haplotype evolution. Gene 281, 81-94.
221. Smith, A.G., Luk, N., Newton, R.A., Roberts, D.W., Sturm, R.A., and Muscat, G.E. (2008). Melanocortin-1 receptor signaling markedly induces the expression of the NR4A nuclear receptor subgroup in melanocytic cells. J. Biol. Chem. 283, 12564-12570.
222. Song, X., Mosby, N., Yang, J., Xu, A., Abdel-Malek, Z., and Kadekaro, A.L. (2009). alpha-MSH activates immediate defense responses to UV-induced oxidative stress in human melanocytes. Pigment Cell Melanoma Res. 22, 809-818.
223. Stefanaki, I., Panagiotou, O.A., Kodela, E. et al. (2013). Replication and predictive value of SNPs associated with melanoma and pigmentation traits in a Southern European case-control study. PLoS ONE 8, e55712.
224. Strange, R.C., Ramachandran, S., Zeegers, M.P., Emes, R.D., Abraham, R., Raveendran, V., Boggild, M., Gilford, J., and Hawkins, C.P. (2010). The Multiple Sclerosis Severity Score: associations with MC1R single nucleotide polymorphisms and host response to ultraviolet radiation. Mult. Scler. 16, 1109-1116.
225. Stratigos, A.J., Dimisianos, G., Nikolaou, V. et al. (2006). Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. J. Invest Dermatol. 126, 1842-1849.
226. Sturm, R.A., Duffy, D.L., Box, N.F., Chen, W., Smit, D.J., Brown, D.L., Stow, J.L., Leonard, J.H., and Martin, N.G. (2003a). The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes. Pigment Cell Res. 16, 266-272.
227. Sturm, R.A., Duffy, D.L., Box, N.F., Newton, R.A., Shepherd, A.G., Chen, W., Marks, L.H., Leonard, J.H., and Martin, N.G. (2003b). Genetic association and cellular function of MC1R variant alleles in human pigmentation. Ann. N. Y. Acad. Sci. 994, 348-358.
228. Suzuki, I., Cone, R.D., Im, S., Nordlund, J., and Abdel-Malek, Z.A. (1996). Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 137, 1627-1633.
229. Suzuki, I., Tada, A., Ollmann, M.M., Barsh, G.S., Im, S., Lamoreux, M.L., Hearing, V.J., Nordlund, J.J., and Abdel-Malek, Z.A. (1997). Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin. J. Invest Dermatol. 108, 838-842.
230. Swope, V.B., Abdel-Malek, Z., Kassem, L.M., and Nordlund, J.J. (1991). Interleukins 1 alpha and 6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J. Invest Dermatol. 96, 180-185.
231. Swope, V.B., Jameson, J.A., McFarland, K.L. et al. (2012). Defining MC1R regulation in human melanocytes by its agonist alpha-melanocortin and antagonists agouti signaling protein and beta-defensin 3. J. Invest Dermatol. 132, 2255-2262.
232. Swope, V.B., Alexander, C., Starner, R. et al. (2014). Significance of the melanocortin 1 receptor in the DNA damage response of human melanocytes to ultraviolet radiation. Pigment Cell Melanoma Res, doi: 10.1111/pcmr.12252
233. Szell, M., Baltas, E., Bodai, L. et al. (2008). The Arg160Trp allele of melanocortin-1 receptor gene might protect against vitiligo. Photochem. Photobiol. 84, 565-571.
234. Tada, A., Suzuki, I., Im, S., Davis, M.B., Cornelius, J., Babcock, G., Nordlund, J.J., and Abdel-Malek, Z.A. (1998). Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiation. Cell Growth Differ. 9, 575-584.
235. Tada, A., Pereira, E., Beitner-Johnson, D., Kavanagh, R., and Abdel-Malek, Z.A. (2002). Mitogen- and ultraviolet-B-induced signaling pathways in normal human melanocytes. J. Invest Dermatol. 118, 316-322.
236. Tamate, H.B., and Takeuchi, T. (1984). Action of the e locus of mice in the response of phaeomelanic hair follicles to alpha-melanocyte-stimulating hormone in vitro. Science 224, 1241-1242.
237. Tan, C.P., McKee, K.K., Weinberg, D.H. et al. (1999). Molecular analysis of a new splice variant of the human melanocortin-1 receptor. FEBS Lett. 451, 137-141.
238. Taylor, S.S., Ilouz, R., Zhang, P., and Kornev, A.P. (2012). Assembly of allosteric macromolecular switches: lessons from PKA. Nat. Rev. Mol. Cell Biol. 13, 646-658.
239. Turan, S., Hughes, C., Atay, Z., Guran, T., Haliloglu, B., Clark, A.J., Bereket, A., and Metherell, L.A. (2012). An atypical case of familial glucocorticoid deficiency without pigmentation caused by coexistent homozygous mutations in MC2R (T152K) and MC1R (R160W). J. Clin. Endocrinol. Metab. 97, E771-E774.
240. Valverde, P., Healy, E., Jackson, I., Rees, J.L., and Thody, A.J. (1995). Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat. Genet. 11, 328-330.
241. Valverde, P., Healy, E., Sikkink, S., Haldane, F., Thody, A.J., Carothers, A., Jackson, I.J., and Rees, J.L. (1996). The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum. Mol. Genet. 5, 1663-1666.
242. Venkatakrishnan, A.J., Deupi, X., Lebon, G., Tate, C.G., Schertler, G.F., and Babu, M.M. (2013). Molecular signatures of G-protein-coupled receptors. Nature 494, 185-194.
243. Voisey, J., and van Daal, A. (2002). Agouti: from mouse to man, from skin to fat. Pigment Cell Res. 15, 10-18.
244. Voisey, J., Gomez-Cabrera, M.C., Smit, D.J., Leonard, J.H., Sturm, R.A., and Van, D.A. (2006). A polymorphism in the agouti signalling protein (ASIP) is associated with decreased levels of mRNA. Pigment Cell Res. 19, 226-231.
245. Wakamatsu, K., Kavanagh, R., Kadekaro, A.L., Terzieva, S., Sturm, R.A., Leachman, S., Abdel-Malek, Z., and Ito, S. (2006). Diversity of pigmentation in cultured human melanocytes is due to differences in the type as well as quantity of melanin. Pigment Cell Res. 19, 154-162.
246. Walker, W.P., and Gunn, T.M. (2010). Shades of meaning: the pigment-type switching system as a tool for discovery. Pigment Cell Melanoma Res. 23, 485-495.
247. Wellbrock, C., Karasarides, M., and Marais, R. (2004). The RAF proteins take centre stage. Nat. Rev. Mol. Cell Biol. 5, 875-885.
248. Wolfe, B.L., and Trejo, J. (2007). Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis. Traffic 8, 462-470.
249. Wong, W., and Minchin, R.F. (1996). Binding and internalization of the melanocyte stimulating hormone receptor ligand [Nle4, D-Phe7] alpha-MSH in B16 melanoma cells. Int. J. Biochem. Cell Biol. 28, 1223-1232.
250. Wong, G., and Pawelek, J. (1973). Control of phenotypic expression of cultured melanoma cells by melanocyte stimulating hormones. Nat. New Biol. 241, 213-215.
251. Wong, S.S., Ainger, S.A., Leonard, J.H., and Sturm, R.A. (2012). MC1R variant allele effects on UVR-induced phosphorylation of p38, p53, and DDB2 repair protein responses in melanocytic cells in culture. J. Invest Dermatol. 132, 1452-1461.
252. Wu, G.S., Luo, H.R., Dong, C., Mastronardi, C., Licinio, J., and Wong, M.L. (2011). Sequence polymorphisms of MC1R gene and their association with depression and antidepressant response. Psychiatr. Genet. 21, 14-18.
253. Yang, Y. (2011). Structure, function and regulation of the melanocortin receptors. Eur. J. Pharmacol. 660, 125-130.
254. Yen, T.T., Gill, A.M., Frigeri, L.G., Barsh, G.S., and Wolff, G.L. (1994). Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti gene. FASEB J. 8, 479-488.
255. Zanna, P.T., Sanchez-Laorden, B.L., Perez-Oliva, A.B., Turpin, M.C., Herraiz, C., Jimenez-Cervantes, C., and Garcia-Borron, J.C. (2008). Mechanism of dimerization of the human melanocortin 1 receptor. Biochem. Biophys. Res. Commun. 368, 211-216.